• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

来自扩大标准尸体供体的肾移植:问题与前景综述

Renal transplantation from extended criteria cadaveric donors: problems and perspectives overview.

作者信息

Audard Vincent, Matignon Marie, Dahan Karine, Lang Philippe, Grimbert Philippe

机构信息

Service de Néphrologie et Transplantation Rénale, CHU Henri Mondor, et Institut Francilien de Recherche en Néphrologie et Transplantation, Université Paris XII, Créteil, France.

出版信息

Transpl Int. 2008 Jan;21(1):11-7. doi: 10.1111/j.1432-2277.2007.00543.x. Epub 2007 Sep 10.

DOI:10.1111/j.1432-2277.2007.00543.x
PMID:17850235
Abstract

The critical shortage of organs available for renal transplantation has led to the consideration of alternative strategies for increasing the donor pool. Recently, the cadaveric kidney donor pool extended to donors who might have been deemed unsuitable in early times, leading to the concept of marginal donors and more recently to the notion of expanded criteria donors. Such organs are eligible for organ donation but, because of extreme age and other clinical characteristics, are expected to produce allograft at risk for diminished post-transplant function. Thus, the challenge is now to reduce the difference between graft outcome from patients grafted with marginal and 'optimal' donors. This implies appropriate transplantation strategies during pre-, peri- and post-transplantation phases including reduction of cold ischemia time, recipient selection, adaptation of immunosuppressive drug regimens, increase in nephron mass by dual kidney transplantation, and improvement in the graft selection process using histological criteria. This review summarizes current definition of a marginal donor and provides some guidance for clinical management of such transplant.

摘要

可用于肾移植的器官严重短缺,这促使人们考虑增加供体库的替代策略。最近,尸体肾供体库已扩大到早期可能被视为不合适的供体,从而产生了边缘供体的概念,最近又出现了扩大标准供体的概念。这类器官有资格进行器官捐献,但由于年龄过大和其他临床特征,预计移植后功能会下降,移植的同种异体移植物存在风险。因此,现在的挑战是缩小接受边缘供体和“最佳”供体移植患者的移植结果差异。这意味着在移植前、移植中和移植后阶段采取适当的移植策略,包括缩短冷缺血时间、受体选择、调整免疫抑制药物方案、通过双肾移植增加肾单位数量,以及使用组织学标准改进移植物选择过程。本综述总结了边缘供体的当前定义,并为这类移植的临床管理提供了一些指导。

相似文献

1
Renal transplantation from extended criteria cadaveric donors: problems and perspectives overview.来自扩大标准尸体供体的肾移植:问题与前景综述
Transpl Int. 2008 Jan;21(1):11-7. doi: 10.1111/j.1432-2277.2007.00543.x. Epub 2007 Sep 10.
2
Older donors and older recipients in kidney transplantation.肾脏移植中的老年供者和老年受者。
J Nephrol. 2010 Sep-Oct;23 Suppl 15:S98-103.
3
Dual kidney transplantation with organs from extended criteria cadaveric donors.使用边缘供体尸体器官进行双肾移植。
J Urol. 2009 Oct;182(4):1477-81. doi: 10.1016/j.juro.2009.06.021. Epub 2009 Aug 15.
4
Expanded criteria donors for kidney transplantation.肾移植扩大标准供体
Transplant Proc. 2005 Nov;37(9):3655-7. doi: 10.1016/j.transproceed.2005.09.118.
5
Organ shortage crisis: problems and possible solutions.器官短缺危机:问题与可能的解决方案。
Transplant Proc. 2008 Jan-Feb;40(1):34-8. doi: 10.1016/j.transproceed.2007.11.067.
6
The role of the urological surgeon in the expansion of the cadaveric donor pool.
Semin Urol. 1994 May;12(2):93-101.
7
Identification of the optimal donor quality scoring system and measure of early renal function in kidney transplantation.肾移植中最佳供体质量评分系统的识别及早期肾功能的测量
Transplantation. 2009 Feb 27;87(4):578-86. doi: 10.1097/TP.0b013e3181949e71.
8
[Kidney transplantation from paediatric cadaveric donors to adult recipients (review article)].[从儿科尸体供体到成年受者的肾移植(综述文章)]
Sb Lek. 2003;104(4):313-32.
9
The status of cadaveric organ donation for liver transplantation in Saudi Arabia.沙特阿拉伯尸体器官捐赠用于肝移植的现状。
Saudi Med J. 2002 May;23(5):509-12.
10
United Network for Organ Sharing's expanded criteria donors: is stratification useful?器官共享联合网络的扩大标准供体:分层是否有用?
Clin Transplant. 2005 Jun;19(3):406-12. doi: 10.1111/j.1399-0012.2005.00365.x.

引用本文的文献

1
The Enhanced Recovery After Surgery Pathway Is Safe, Feasible and Cost-Effective in Delayed Graft Function After Kidney Transplant.手术后加速康复方案在肾移植术后移植肾功能延迟恢复中是安全、可行且具有成本效益的。
J Clin Med. 2025 Mar 31;14(7):2387. doi: 10.3390/jcm14072387.
2
Physiological arterial pressure improves renal performance during normothermic machine perfusion in a porcine kidney DCD model.在猪肾DCD模型的常温机器灌注过程中,生理动脉压可改善肾脏功能。
Heliyon. 2025 Jan 10;11(2):e41610. doi: 10.1016/j.heliyon.2024.e41610. eCollection 2025 Jan 30.
3
Perirenal Adipose Tissue Displays an Age-Dependent Inflammatory Signature Associated With Early Graft Dysfunction of Marginal Kidney Transplants.
肾周脂肪组织呈现出与边缘肾移植早期移植物功能障碍相关的年龄依赖性炎症特征。
Front Immunol. 2020 Mar 17;11:445. doi: 10.3389/fimmu.2020.00445. eCollection 2020.
4
Development and validation of a new prediction model for graft function using preoperative marginal factors in living-donor kidney transplantation.利用活体供肾移植术前边缘因素开发和验证一种新的移植物功能预测模型。
Clin Exp Nephrol. 2019 Nov;23(11):1331-1340. doi: 10.1007/s10157-019-01774-x. Epub 2019 Aug 23.
5
Fifteen-Year Analysis of Deceased Kidney Donation: A Single Transplant Center Experience in a Region of Northern Italy.15 年死亡供肾分析:意大利北部某地区单移植中心经验。
Med Sci Monit. 2017 Sep 18;23:4482-4489. doi: 10.12659/msm.903513.
6
Experiences of renal transplants from donors with renal cell carcinoma after partial nephrectomy.肾部分切除术后肾细胞癌供体肾移植的经验。
Ann Surg Treat Res. 2017 May;92(5):361-364. doi: 10.4174/astr.2017.92.5.361. Epub 2017 Apr 27.
7
Long-Term Outcomes in Belatacept- Versus Cyclosporine-Treated Recipients of Extended Criteria Donor Kidneys: Final Results From BENEFIT-EXT, a Phase III Randomized Study.接受贝拉西普与环孢素治疗的扩大标准供肾受者的长期预后:III期随机研究BENEFIT-EXT的最终结果
Am J Transplant. 2016 Nov;16(11):3192-3201. doi: 10.1111/ajt.13830. Epub 2016 Jun 9.
8
Comparison of clinical outcomes between ABO-compatible and ABO-incompatible spousal donor kidney transplantation.ABO 血型相容与不相容配偶供肾移植的临床结局比较。
Kidney Res Clin Pract. 2016 Mar;35(1):50-4. doi: 10.1016/j.krcp.2015.11.001. Epub 2016 Jan 13.
9
Access to Transplantation and Transplant Outcome Measures (ATTOM): study protocol of a UK wide, in-depth, prospective cohort analysis.移植获取与移植结果测量(ATTOM):一项全英国范围的深入前瞻性队列分析研究方案
BMJ Open. 2016 Feb 25;6(2):e010377. doi: 10.1136/bmjopen-2015-010377.
10
Class-specific histone/protein deacetylase inhibition protects against renal ischemia reperfusion injury and fibrosis formation.特异性组蛋白/蛋白去乙酰化酶抑制可预防肾缺血再灌注损伤和纤维化形成。
Am J Transplant. 2015 Apr;15(4):965-73. doi: 10.1111/ajt.13106. Epub 2015 Feb 23.